SEPIDEH KHALILIAN
Allopathic & Osteopathic Physicians|Obstetrics & Gynecology ARLINGTON, VA NPI 1437313665
Browse related groups: Allopathic & Osteopathic Physicians|Obstetrics & Gynecology VA ABBVIE INC. All categories
General Payments — all program years on this page
$332.18
- Category: General Payments
- Program years: PY2018–2021
- Record count: 10
- As of (CMS publication): 2026-01-23
Latest program year (PY2021): $207.18 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2021) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $207.18 | 9 |
By paying entity
Latest program year (PY2021) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $122.19 | 4 |
| Evofem Biosciences, Inc. | $32.36 | 2 |
| Linvatec Corporation | $21.01 | 1 |
| Amgen Inc. | $16.96 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.66 | 1 |
By program year
Records — PY2021 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 789092943 | Bayer HealthCare Pharmaceuticals Inc. | $14.66 | 09/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 795077917 | AbbVie Inc. | $2.92 | 02/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 795077921 | AbbVie Inc. | $2.54 | 10/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 795077923 | AbbVie Inc. | $114.06 | 11/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 795077927 | AbbVie Inc. | $2.67 | 12/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 825778017 | Amgen Inc. | $16.96 | 10/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 853514667 | Linvatec Corporation | $21.01 | 01/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 855180519 | Evofem Biosciences, Inc. | $15.01 | 09/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 855180521 | Evofem Biosciences, Inc. | $17.35 | 10/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.